# Ticagrelor Versus Clopidogrel in Carotid Artery Stenting

> **NCT02677545** · PHASE2 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 210 (actual)

## Conditions studied

- Carotid Artery Stenosis

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT02677545
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2022-04-28
- **Final completion:** 2022-04-28
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2022-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02677545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02677545, "Ticagrelor Versus Clopidogrel in Carotid Artery Stenting". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02677545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*